9
908 Devices
Mass Spectrometry and chemical analysis
About 908 Devices
908 Devices is a pioneering company in the field of chemical and biochemical analysis, offering innovative solutions that span multiple industries. Their primary focus is on life science research, biopharmaceuticals, and forensics. The company’s technology is designed to provide rapid, accurate, and actionable data, which is crucial for making informed decisions in critical applications.
908 Devices serves a diverse range of clients, including academic researchers, pharmaceutical companies, forensic laboratories, and government agencies. These clients rely on 908 Devices' products to streamline their analytical processes, reduce time-to-results, and enhance the accuracy of their data.
Operating in the analytical instrumentation market, 908 Devices has carved out a niche by developing both handheld and desktop devices that simplify complex chemical analyses. Their flagship products, such as the REBEL and ZipChip, are designed to provide near real-time data and significantly reduce analysis times. For example, the REBEL device offers instant amino acid profiling, allowing users to make process decisions during experiments. Similarly, the ZipChip device enhances sample preparation and separation, enabling faster and more efficient metabolomic and proteomic analyses.
The business model of 908 Devices revolves around the sale of these advanced analytical instruments, along with associated consumables and software. They generate revenue through direct sales, as well as through service contracts and maintenance agreements. By offering cutting-edge technology that improves the efficiency and effectiveness of chemical analysis, 908 Devices provides significant value to its clients, which in turn drives its financial performance.
In summary, 908 Devices is revolutionizing the field of chemical and biochemical analysis with its innovative, user-friendly products that deliver rapid and reliable results. Their commitment to making a difference in critical applications sets them apart in the industry.
Source: Dealroom company dataAt a glance
- Status
- Listed
- Founded
- 2012
- Headquarters
- Burlington, United States
- Listing
- IPO 2021
- Sector
- Biotech & Life Sciences
- Power Law
- Colt$25–100M revenue
Knowledge graph
More headlines
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A3 investors entered at this stage
ARCH Venture Partners
In-Q-Tel
Razor's Edge Ventures
Series B and later5 investors entered at this stage
Aramco Ventures
Tao Capital Partners
Casdin Capital
Cormorant Asset Management
Northpond Ventures
Source: Dealroom Talent Intelligence.
Global footprint
team presence
across markets
Market sentiment
An AI-synthesised read of the highest-engagement posts about 908 Devices on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See 908 Devices on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.